<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 54-year-old <z:mp ids='MP_0001261'>obese</z:mp> woman with poorly controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was put on the maximum allowed doses of <z:chebi fb="0" ids="6801">Metformin</z:chebi>, <z:chebi fb="0" ids="5383">Glimepiride</z:chebi> and <z:chebi fb="0" ids="50122">Rosiglitazone</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>When Exenatide was added, she lost 33 kg </plain></SENT>
<SENT sid="2" pm="."><plain>She remained euglycemic for at least 7 months after the sequential discontinuation of Exenatide and the other oral agents </plain></SENT>
</text></document>